|
Genzyme Websites
Genzyme Business Sites
 | Genzyme Biosurgery
Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products, including Carticel ® and Synvisc ®.
|
| Genzyme Diagnostics
Genzyme Diagnostics offers a unique product portfolio for diagnostic manufacturers and clinical laboratories worldwide, with three key product areas: clinical chemistry, rapid tests and point of care diagnostics.
|
| Genzyme Genetics
Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services.
|
| Genzyme Oncology
Genzyme Oncology is focused on developing and commercializing novel treatments for cancer patients. It has a full pipeline and two marketed therapeutics: Campath ® and Clolar ®.
|
| Genzyme Pharmaceuticals
Genzyme Pharmaceuticals develops and manufactures specialty pharmaceutical/drug materials and value added technologies, products and services with an immediate focus in the lipid, peptide, amino acid derivatives and drug delivery markets. |
Genzyme Joint Venture Site
| MG Biotherapeutics
MG Biotherapeutics is a Medtronic-Genzyme joint venture to develop cell therapy solutions for unmet medical needs in cardiovascular disease through the combination of biologics and delivery devices. |
Genzyme Product Sites for US Audiences
| Aldurazyme®
Aldurazyme (laronidase) is an enzyme replacement therapy for mucopolysaccharidosis I (MPS I).
|
| Campath®
Campath (alemtuzumab for injection) is indicated for the treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and have failed fludarabine therapy.
|
| Carticel®
Carticel (autologous cultured chondrocytes) employs a unique process to grow a patient’s own cartilage cells for implantation to correct certain types of knee cartilage damage.
|
| Cerezyme®
Cerezyme (imiglucerase for injection) is an enzyme replacement therapy for Type 1 Gaucher disease.
|
| Clolar®
Clolar (clofarabine) is indicated for the treatment of children with refractory or relapsed acute lymphoblastic leukemia (ALL).
|
| Epicel®
Epicel (cultured epidermal autografts) is a permanent skin replacement product that is available for patients with life-threatening burns.
|
| Fabrazyme®
Fabrazyme (agalsidase beta) is an enzyme replacement therapy for Fabry disease.
|
| Hectorol®
Hectorol (doxercalciferol) is indicated for the treatment of secondary hyperparathyroidism in patients with stage 3 or stage 4 chronic kidney disease and patients with stage 5 chronic kidney disease on dialysis.
|
| Myozyme®
Myozyme (alglucosidase alfa) is an enzyme replacement therapy for Pompe disease.
|
| Renagel®
Renagel (sevelamer hydrochloride) is a calcium-free, metal-free phosphate binder that controls serum phosphorus levels in patients with chronic kidney disease on hemodialysis.
|
| Renvela®
Renvela (sevelamer carbonate)is a next-generation version of Renagel® (sevelamer hydrochloride), the most-prescribed phosphate binder in the United States.
|
| Seprafilm®
Seprafilm is a temporary, physical adhesion barrier for abdominal and pelvic adhesion prevention.
|
| Thymoglobulin®
Thymoglobulin [Anti-thymocyte Globulin (Rabbit)] is an immunosuppressive polyclonal antibody that is used in conjunction with concomitant immunosuppression to treat acute rejection in kidney transplant patients.
|
| Thyrogen®
Thyrogen (thyrotropin alfa for injection) is an adjunctive diagnostic used in follow-up screenings of cancer patients with well-differentiated thyroid cancer who have had their thyroid glands removed. |
Genzyme Product Sites for EU Audiences
Genzyme Disease Education/Research/Support Sites
Genzyme International Subsidiaries Sites
|
|
|
Genzyme Corporate
Genzyme Websites
